nodes	percent_of_prediction	percent_of_DWPC	metapath
Rotigotine—DRD5—attention deficit hyperactivity disorder	0.312	0.372	CbGaD
Rotigotine—DRD4—attention deficit hyperactivity disorder	0.16	0.19	CbGaD
Rotigotine—DRD3—attention deficit hyperactivity disorder	0.138	0.164	CbGaD
Rotigotine—DRD1—attention deficit hyperactivity disorder	0.135	0.161	CbGaD
Rotigotine—DRD2—attention deficit hyperactivity disorder	0.0952	0.113	CbGaD
Rotigotine—DRD5—forebrain—attention deficit hyperactivity disorder	0.00143	0.0827	CbGeAlD
Rotigotine—DRD1—forebrain—attention deficit hyperactivity disorder	0.00109	0.0632	CbGeAlD
Rotigotine—DRD4—brain—attention deficit hyperactivity disorder	0.000901	0.0521	CbGeAlD
Rotigotine—DRD3—nervous system—attention deficit hyperactivity disorder	0.000828	0.0479	CbGeAlD
Rotigotine—DRD3—central nervous system—attention deficit hyperactivity disorder	0.000798	0.0461	CbGeAlD
Rotigotine—DRD5—nervous system—attention deficit hyperactivity disorder	0.000776	0.0449	CbGeAlD
Rotigotine—DRD5—central nervous system—attention deficit hyperactivity disorder	0.000748	0.0432	CbGeAlD
Rotigotine—DRD1—midbrain—attention deficit hyperactivity disorder	0.000722	0.0417	CbGeAlD
Rotigotine—HTR1A—forebrain—attention deficit hyperactivity disorder	0.000715	0.0413	CbGeAlD
Rotigotine—DRD2—forebrain—attention deficit hyperactivity disorder	0.000646	0.0373	CbGeAlD
Rotigotine—DRD3—brain—attention deficit hyperactivity disorder	0.000633	0.0366	CbGeAlD
Rotigotine—HTR1A—cardiovascular system—attention deficit hyperactivity disorder	0.000604	0.0349	CbGeAlD
Rotigotine—DRD5—brain—attention deficit hyperactivity disorder	0.000593	0.0343	CbGeAlD
Rotigotine—DRD1—nervous system—attention deficit hyperactivity disorder	0.000593	0.0343	CbGeAlD
Rotigotine—DRD1—central nervous system—attention deficit hyperactivity disorder	0.000571	0.033	CbGeAlD
Rotigotine—HTR1A—midbrain—attention deficit hyperactivity disorder	0.000472	0.0273	CbGeAlD
Rotigotine—DRD1—brain—attention deficit hyperactivity disorder	0.000453	0.0262	CbGeAlD
Rotigotine—DRD2—midbrain—attention deficit hyperactivity disorder	0.000426	0.0247	CbGeAlD
Rotigotine—CYP2D6—forebrain—attention deficit hyperactivity disorder	0.000388	0.0224	CbGeAlD
Rotigotine—HTR1A—nervous system—attention deficit hyperactivity disorder	0.000388	0.0224	CbGeAlD
Rotigotine—HTR1A—central nervous system—attention deficit hyperactivity disorder	0.000373	0.0216	CbGeAlD
Rotigotine—HTR1A—cerebellum—attention deficit hyperactivity disorder	0.000365	0.0211	CbGeAlD
Rotigotine—DRD2—nervous system—attention deficit hyperactivity disorder	0.00035	0.0203	CbGeAlD
Rotigotine—DRD2—central nervous system—attention deficit hyperactivity disorder	0.000337	0.0195	CbGeAlD
Rotigotine—DRD2—cerebellum—attention deficit hyperactivity disorder	0.00033	0.0191	CbGeAlD
Rotigotine—HTR1A—brain—attention deficit hyperactivity disorder	0.000296	0.0171	CbGeAlD
Rotigotine—DRD2—brain—attention deficit hyperactivity disorder	0.000268	0.0155	CbGeAlD
Rotigotine—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.000214	0.0124	CbGeAlD
Rotigotine—CYP2D6—nervous system—attention deficit hyperactivity disorder	0.000211	0.0122	CbGeAlD
Rotigotine—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.000206	0.0119	CbGeAlD
Rotigotine—CYP2D6—central nervous system—attention deficit hyperactivity disorder	0.000203	0.0117	CbGeAlD
Rotigotine—CYP2D6—cerebellum—attention deficit hyperactivity disorder	0.000198	0.0115	CbGeAlD
Rotigotine—CYP2D6—brain—attention deficit hyperactivity disorder	0.000161	0.00931	CbGeAlD
Rotigotine—DRD2—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	3.87e-05	0.00027	CbGpPWpGaD
Rotigotine—DRD4—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	3.87e-05	0.00027	CbGpPWpGaD
Rotigotine—DRD5—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	3.87e-05	0.00027	CbGpPWpGaD
Rotigotine—ADRA2B—Hemostasis—ADRA2A—attention deficit hyperactivity disorder	3.8e-05	0.000265	CbGpPWpGaD
Rotigotine—DRD2—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	3.79e-05	0.000265	CbGpPWpGaD
Rotigotine—DRD2—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	3.78e-05	0.000264	CbGpPWpGaD
Rotigotine—HTR1A—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	3.77e-05	0.000263	CbGpPWpGaD
Rotigotine—DRD5—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	3.75e-05	0.000261	CbGpPWpGaD
Rotigotine—DRD5—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	3.73e-05	0.00026	CbGpPWpGaD
Rotigotine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—attention deficit hyperactivity disorder	3.7e-05	0.000258	CbGpPWpGaD
Rotigotine—CYP1A2—Aryl Hydrocarbon Receptor—EP300—attention deficit hyperactivity disorder	3.7e-05	0.000258	CbGpPWpGaD
Rotigotine—DRD5—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	3.68e-05	0.000257	CbGpPWpGaD
Rotigotine—DRD2—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	3.66e-05	0.000255	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	3.65e-05	0.000255	CbGpPWpGaD
Rotigotine—DRD5—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	3.64e-05	0.000254	CbGpPWpGaD
Rotigotine—DRD2—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	3.6e-05	0.000251	CbGpPWpGaD
Rotigotine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	3.59e-05	0.000251	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	3.56e-05	0.000248	CbGpPWpGaD
Rotigotine—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	3.55e-05	0.000248	CbGpPWpGaD
Rotigotine—DRD2—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	3.55e-05	0.000248	CbGpPWpGaD
Rotigotine—CYP2D6—Biological oxidations—COMT—attention deficit hyperactivity disorder	3.54e-05	0.000247	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	3.53e-05	0.000246	CbGpPWpGaD
Rotigotine—CYP2D6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	3.52e-05	0.000245	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	3.52e-05	0.000245	CbGpPWpGaD
Rotigotine—DRD4—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	3.51e-05	0.000245	CbGpPWpGaD
Rotigotine—CYP2D6—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	3.49e-05	0.000244	CbGpPWpGaD
Rotigotine—DRD1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	3.48e-05	0.000243	CbGpPWpGaD
Rotigotine—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	3.47e-05	0.000242	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	3.44e-05	0.00024	CbGpPWpGaD
Rotigotine—DRD3—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	3.44e-05	0.00024	CbGpPWpGaD
Rotigotine—DRD4—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	3.41e-05	0.000238	CbGpPWpGaD
Rotigotine—DRD5—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	3.39e-05	0.000236	CbGpPWpGaD
Rotigotine—DRD4—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	3.38e-05	0.000236	CbGpPWpGaD
Rotigotine—DRD4—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	3.38e-05	0.000236	CbGpPWpGaD
Rotigotine—HTR1A—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	3.21e-05	0.000224	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	3.2e-05	0.000223	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	3.16e-05	0.000221	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	3.16e-05	0.00022	CbGpPWpGaD
Rotigotine—DRD4—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	3.14e-05	0.000219	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	3.12e-05	0.000218	CbGpPWpGaD
Rotigotine—ADRA2B—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	3.1e-05	0.000216	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	3.1e-05	0.000216	CbGpPWpGaD
Rotigotine—DRD1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	3.07e-05	0.000214	CbGpPWpGaD
Rotigotine—DRD4—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	3.07e-05	0.000214	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	3.06e-05	0.000213	CbGpPWpGaD
Rotigotine—DRD1—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	3.05e-05	0.000212	CbGpPWpGaD
Rotigotine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	3.05e-05	0.000212	CbGpPWpGaD
Rotigotine—DRD4—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	3.04e-05	0.000212	CbGpPWpGaD
Rotigotine—DRD1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	3.04e-05	0.000212	CbGpPWpGaD
Rotigotine—DRD3—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	3.03e-05	0.000211	CbGpPWpGaD
Rotigotine—DRD3—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	3.01e-05	0.00021	CbGpPWpGaD
Rotigotine—DRD3—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	3e-05	0.000209	CbGpPWpGaD
Rotigotine—CYP1A2—Biological oxidations—COMT—attention deficit hyperactivity disorder	3e-05	0.000209	CbGpPWpGaD
Rotigotine—HTR1A—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	2.99e-05	0.000209	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	2.99e-05	0.000209	CbGpPWpGaD
Rotigotine—DRD4—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	2.99e-05	0.000209	CbGpPWpGaD
Rotigotine—CYP1A2—Biological oxidations—MAOA—attention deficit hyperactivity disorder	2.98e-05	0.000208	CbGpPWpGaD
Rotigotine—CYP1A2—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	2.96e-05	0.000206	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	2.94e-05	0.000205	CbGpPWpGaD
Rotigotine—DRD4—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	2.85e-05	0.000199	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	2.85e-05	0.000199	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	2.82e-05	0.000196	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2.81e-05	0.000196	CbGpPWpGaD
Rotigotine—DRD3—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	2.79e-05	0.000195	CbGpPWpGaD
Rotigotine—DRD4—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	2.76e-05	0.000193	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	2.76e-05	0.000193	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	2.75e-05	0.000192	CbGpPWpGaD
Rotigotine—DRD4—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	2.75e-05	0.000192	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	2.75e-05	0.000192	CbGpPWpGaD
Rotigotine—DRD1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	2.74e-05	0.000191	CbGpPWpGaD
Rotigotine—ADRA2B—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	2.74e-05	0.000191	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	2.73e-05	0.00019	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	2.72e-05	0.00019	CbGpPWpGaD
Rotigotine—DRD4—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	2.72e-05	0.00019	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	2.71e-05	0.000189	CbGpPWpGaD
Rotigotine—ADRA2B—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	2.71e-05	0.000189	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	2.7e-05	0.000188	CbGpPWpGaD
Rotigotine—DRD1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	2.69e-05	0.000188	CbGpPWpGaD
Rotigotine—DRD1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	2.66e-05	0.000186	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	2.66e-05	0.000185	CbGpPWpGaD
Rotigotine—DRD3—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	2.66e-05	0.000185	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	2.64e-05	0.000184	CbGpPWpGaD
Rotigotine—HTR1A—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	2.64e-05	0.000184	CbGpPWpGaD
Rotigotine—DRD2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	2.63e-05	0.000183	CbGpPWpGaD
Rotigotine—DRD3—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	2.63e-05	0.000183	CbGpPWpGaD
Rotigotine—HTR1A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	2.62e-05	0.000183	CbGpPWpGaD
Rotigotine—DRD5—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	2.61e-05	0.000182	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	2.61e-05	0.000182	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	2.54e-05	0.000177	CbGpPWpGaD
Rotigotine—ADRA2B—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	2.52e-05	0.000176	CbGpPWpGaD
Rotigotine—DRD4—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	2.5e-05	0.000174	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	2.49e-05	0.000174	CbGpPWpGaD
Rotigotine—DRD1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	2.48e-05	0.000173	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	2.46e-05	0.000172	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	2.46e-05	0.000171	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	2.45e-05	0.000171	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	2.45e-05	0.000171	CbGpPWpGaD
Rotigotine—DRD3—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	2.45e-05	0.000171	CbGpPWpGaD
Rotigotine—ADRA2B—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	2.44e-05	0.00017	CbGpPWpGaD
Rotigotine—HTR1A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	2.43e-05	0.00017	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	2.42e-05	0.000169	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	2.42e-05	0.000169	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	2.41e-05	0.000168	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	2.4e-05	0.000167	CbGpPWpGaD
Rotigotine—ADRA2B—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	2.4e-05	0.000167	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	2.39e-05	0.000167	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	2.38e-05	0.000166	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	2.38e-05	0.000166	CbGpPWpGaD
Rotigotine—DRD5—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	2.37e-05	0.000165	CbGpPWpGaD
Rotigotine—ADRA2B—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	2.37e-05	0.000165	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	2.37e-05	0.000165	CbGpPWpGaD
Rotigotine—HTR1A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	2.36e-05	0.000164	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	2.35e-05	0.000164	CbGpPWpGaD
Rotigotine—DRD2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	2.32e-05	0.000162	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	2.32e-05	0.000162	CbGpPWpGaD
Rotigotine—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	2.32e-05	0.000162	CbGpPWpGaD
Rotigotine—HTR1A—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	2.32e-05	0.000162	CbGpPWpGaD
Rotigotine—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	2.3e-05	0.00016	CbGpPWpGaD
Rotigotine—DRD2—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	2.3e-05	0.00016	CbGpPWpGaD
Rotigotine—DRD2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	2.3e-05	0.00016	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	2.29e-05	0.00016	CbGpPWpGaD
Rotigotine—HTR1A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	2.29e-05	0.00016	CbGpPWpGaD
Rotigotine—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	2.28e-05	0.000159	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	2.28e-05	0.000159	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	2.27e-05	0.000159	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	2.25e-05	0.000157	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	2.22e-05	0.000155	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	2.22e-05	0.000155	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	2.21e-05	0.000154	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	2.21e-05	0.000154	CbGpPWpGaD
Rotigotine—ADRA2B—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	2.21e-05	0.000154	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	2.18e-05	0.000152	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	2.18e-05	0.000152	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	2.15e-05	0.00015	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	2.15e-05	0.00015	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	2.14e-05	0.000149	CbGpPWpGaD
Rotigotine—DRD2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	2.14e-05	0.000149	CbGpPWpGaD
Rotigotine—HTR1A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	2.13e-05	0.000149	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	2.1e-05	0.000147	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	2.09e-05	0.000146	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	2.08e-05	0.000145	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	2.08e-05	0.000145	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2.08e-05	0.000145	CbGpPWpGaD
Rotigotine—DRD2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	2.07e-05	0.000144	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	2.03e-05	0.000142	CbGpPWpGaD
Rotigotine—DRD2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	2.03e-05	0.000142	CbGpPWpGaD
Rotigotine—DRD2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	2.01e-05	0.00014	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	2.01e-05	0.00014	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	2e-05	0.00014	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	2e-05	0.000139	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	1.94e-05	0.000135	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.94e-05	0.000135	CbGpPWpGaD
Rotigotine—DRD4—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.93e-05	0.000134	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	1.88e-05	0.000131	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.87e-05	0.00013	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	1.85e-05	0.000129	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.84e-05	0.000129	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	1.82e-05	0.000127	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.81e-05	0.000127	CbGpPWpGaD
Rotigotine—DRD4—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.75e-05	0.000122	CbGpPWpGaD
Rotigotine—DRD1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.74e-05	0.000121	CbGpPWpGaD
Rotigotine—DRD3—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.71e-05	0.000119	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.69e-05	0.000118	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.66e-05	0.000116	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.63e-05	0.000114	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.63e-05	0.000114	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.61e-05	0.000112	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.61e-05	0.000112	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.61e-05	0.000112	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.58e-05	0.00011	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.56e-05	0.000108	CbGpPWpGaD
Rotigotine—ADRA2B—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.55e-05	0.000108	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.5e-05	0.000104	CbGpPWpGaD
Rotigotine—HTR1A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.49e-05	0.000104	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.48e-05	0.000103	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.47e-05	0.000103	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.45e-05	0.000101	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	1.45e-05	0.000101	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.45e-05	0.000101	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.43e-05	9.95e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.43e-05	9.94e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.41e-05	9.84e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.41e-05	9.82e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.4e-05	9.79e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.4e-05	9.79e-05	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.4e-05	9.78e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.36e-05	9.45e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.35e-05	9.43e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.33e-05	9.27e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.31e-05	9.15e-05	CbGpPWpGaD
Rotigotine—DRD2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.31e-05	9.14e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.31e-05	9.13e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.31e-05	9.1e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Hemostasis—EP300—attention deficit hyperactivity disorder	1.3e-05	9.04e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.29e-05	8.98e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.27e-05	8.87e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.26e-05	8.82e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.24e-05	8.67e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.23e-05	8.6e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	1.23e-05	8.56e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.23e-05	8.56e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.19e-05	8.3e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.18e-05	8.26e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.15e-05	7.99e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.14e-05	7.97e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.11e-05	7.74e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.09e-05	7.61e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.08e-05	7.52e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.03e-05	7.21e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	1e-05	6.98e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	1e-05	6.98e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	9.84e-06	6.86e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	9.47e-06	6.61e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	9.31e-06	6.49e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	9.19e-06	6.41e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	9.15e-06	6.38e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—TPH2—attention deficit hyperactivity disorder	8.47e-06	5.91e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—CACNB2—attention deficit hyperactivity disorder	8.47e-06	5.91e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—DPYD—attention deficit hyperactivity disorder	8.34e-06	5.81e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	8.3e-06	5.79e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	8.01e-06	5.59e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	8e-06	5.58e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	7.75e-06	5.4e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	7.61e-06	5.31e-05	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—EP300—attention deficit hyperactivity disorder	7.43e-06	5.18e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	7.03e-06	4.9e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—SNAP25—attention deficit hyperactivity disorder	6.77e-06	4.72e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	6.54e-06	4.56e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	6.54e-06	4.56e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	6.45e-06	4.5e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	6.43e-06	4.49e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	6.06e-06	4.23e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	6.02e-06	4.2e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	5.98e-06	4.17e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—EP300—attention deficit hyperactivity disorder	5.48e-06	3.82e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	5.23e-06	3.65e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—COMT—attention deficit hyperactivity disorder	5.13e-06	3.58e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—MAOA—attention deficit hyperactivity disorder	5.1e-06	3.55e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	4.98e-06	3.47e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	4.94e-06	3.45e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	4.93e-06	3.44e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—EP300—attention deficit hyperactivity disorder	4.87e-06	3.4e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—EP300—attention deficit hyperactivity disorder	4.4e-06	3.07e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	4.24e-06	2.96e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	3.96e-06	2.76e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	3.93e-06	2.74e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.73e-06	2.6e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	2.6e-06	1.81e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—EP300—attention deficit hyperactivity disorder	2.2e-06	1.54e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	1.7e-06	1.18e-05	CbGpPWpGaD
